CIP
CLB icon

Cornerstone Investment Partners’s Core Laboratories CLB Stock Holding History

Cornerstone Investment Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,381
Closed -$182K – 301
2025
Q4 		$182K Buy
+11,381
New +$169K 0.01% 186

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Investment Partners's CLB Position: Q1 2026 in Review

Cornerstone Investment Partners sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 11,381 shares — an estimated $182K sold.

Cornerstone Investment Partners first reported a position in CLB in Q4 2025 and held it in 1 quarter. The position peaked at $182K in Q4 2025. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Cornerstone Investment Partners reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
  • Cornerstone Investment Partners sold 11,381 Core Laboratories shares in Q1 2026, an estimated $182K.
  • Cornerstone Investment Partners first reported a position in Core Laboratories in Q4 2025 and held it in 1 quarter.
  • Cornerstone Investment Partners's Core Laboratories position peaked at $182K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Cornerstone Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.